首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   259091篇
  免费   18719篇
  国内免费   1149篇
耳鼻咽喉   2907篇
儿科学   6707篇
妇产科学   4694篇
基础医学   33979篇
口腔科学   5347篇
临床医学   25839篇
内科学   55395篇
皮肤病学   3498篇
神经病学   24784篇
特种医学   8561篇
外国民族医学   13篇
外科学   39153篇
综合类   3493篇
一般理论   321篇
预防医学   22213篇
眼科学   6670篇
药学   17512篇
  6篇
中国医学   402篇
肿瘤学   17465篇
  2023年   1405篇
  2022年   2581篇
  2021年   5685篇
  2020年   3426篇
  2019年   5516篇
  2018年   6216篇
  2017年   4653篇
  2016年   5183篇
  2015年   6081篇
  2014年   8925篇
  2013年   12193篇
  2012年   18642篇
  2011年   19528篇
  2010年   10930篇
  2009年   9720篇
  2008年   17056篇
  2007年   17909篇
  2006年   17699篇
  2005年   17611篇
  2004年   16469篇
  2003年   15277篇
  2002年   14274篇
  2001年   2230篇
  2000年   1746篇
  1999年   2450篇
  1998年   3109篇
  1997年   2602篇
  1996年   2211篇
  1995年   2111篇
  1994年   1766篇
  1993年   1587篇
  1992年   1318篇
  1991年   1200篇
  1990年   1046篇
  1989年   1021篇
  1988年   1009篇
  1987年   977篇
  1986年   984篇
  1985年   1007篇
  1984年   1250篇
  1983年   1144篇
  1982年   1375篇
  1981年   1327篇
  1980年   1161篇
  1979年   713篇
  1978年   760篇
  1977年   645篇
  1976年   596篇
  1975年   485篇
  1974年   474篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
7.
8.
9.
Academic output is just one aspect of a successful career as a plastic surgeon. However, for those with a strong interest in academia, the academic output of a department will likely be a key factor when deciding how to rank jobs. The aim of this study was to quantify and rank the academic output of plastic surgery units across the UK and Ireland. The Institute for Scientific Information (ISI) Web of Science Bibliometric analysis tool was used to collate cumulative (1950–2016), 10 year (2006–2016) and 3 years (2013–2015) research output data for plastic surgery units in the UK and Ireland. Sixty-six plastic surgery units were identified. Departments were ranked for each time period according to the number of papers produced, number of citations (Nc) and h-index (a measure of the impact of scientific output). The top 3 departments for number of papers in the last 10 years were The Royal Free Hospital, London (226) Broomfield Hospital, Chelmsford (218), and Morriston Hospital and Swansea (188). The top 3 for h-number were The Royal Free Hospital (21) Wythenshawe Hospital, Manchester (18) and Morriston Hospital (17). Academic output varies across plastic surgery units in the UK and Ireland. A number of departments have consistently maintained high academic outputs across the years and will be of interest to surgeons hoping to pursue a career in academia.  相似文献   
10.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号